Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 1.16% institutional investors, 1.44% insiders, and 97.39% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.80% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical1.16%1.44%97.39%
SectorHealthcare Stocks 212.97%10.98%-123.95%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.17%11.29%54.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.34M16.80%$157.96M
Eventide asset management2.64M8.31%$78.11M
Rubric capital management lp2.35M7.28%$67.33M
Vanguard group2.28M7.08%$65.40M
Pacer advisors2.14M6.64%$61.38M
Invesco1.78M5.50%$50.88M
Renaissance1.66M5.15%$47.60M
Principal financial group1.65M5.10%$47.13M
Fuller & thaler asset management1.43M4.50%$42.32M
State street1.44M4.46%$41.17M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tejara capital107.34K1.47%$3.17M
Eventide asset management2.64M1.37%$78.11M
Ballast asset management, lp87.21K1.34%$2.58M
Third avenue management203.40K1.24%$6.01M
Stonepine capital management41.50K1.20%$1.23M
Emerald mutual fund advisers trust550.63K0.99%$16.28M
Emerald advisers837.55K0.91%$24.77M
Rubric capital management lp2.35M0.86%$67.33M
Summerhaven investment management24.87K0.48%$735.35K
Uniplan investment counsel130.43K0.39%$3.86M

Top Buyers

HolderShares% AssetsChange
Rubric capital management lp2.35M0.86%1.10M
Millennium management647.83K0.01%461.91K
Invesco1.78M0.01%289.33K
J. goldman & co lp243.45K0.17%243.45K
Janus henderson group291.39K0.00%221.90K

Top Sellers

HolderShares% AssetsChange
Pacer advisors2.14M0.13%-447.16K
Goldman sachs group219.71K0.00%-355.53K
Federated hermes3.07K0.00%-327.43K
Arrowstreet capital, limited partnership---276.73K
Quantedge capital pte---237.75K

New Positions

HolderShares% AssetsChangeValue
J. goldman & co lp243.45K0.17%243.45K$7.20M
Marshall wace, llp136.72K0.00%136.72K$4.04M
Ballast asset management, lp87.21K1.34%87.21K$2.58M
Fred alger management35.25K0.00%35.25K$903.07K
Voloridge investment management26.14K0.00%26.14K$773.08K

Sold Out

HolderChange
Lindbrook capital-2.00
Mendota financial group-4.00
Ifp advisors-8.00
Toth financial advisory-11.00
Cornerstone planning group-15.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20252-99.17%369,275-99.01%10.01%1-99.07%1-98.91%
Dec 31, 2024239-5.16%37,025,520-3.74%1140.81%105-25.53%9322.37%
Sep 30, 20242528.15%38,464,415-2.96%1190.79%1418.46%76-
Jun 30, 20242330.43%39,636,436-0.49%1220.81%130-76-3.80%
Mar 31, 202423218.97%39,833,4831.57%1230.84%13042.86%792.60%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.92M6.09%322.00
Eventide Gilead N1.34M4.18%-
FullerThaler Behavioral Sm-Cp Eq R61.31M4.06%-
FullerThaler Behavioral Small-Cap Equity1.31M4.06%-
Eventide Healthcare & Life Sciences I1.29M4.00%-
Vanguard US Total Market Shares ETF993.93K3.09%-
Vanguard Total Stock Mkt Idx Inv957.93K3.04%-21.24K
iShares Russell 2000 ETF757.08K2.40%-14.38K
Principal SmallCap R5551.90K1.72%-13.50K
Principal U.S. Small Cap Equity551.90K1.72%-16.00K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 13, 2025Dreyer Scott EVP & Chief Commercial OfficerSell$184.88K
Aug 13, 2025Rubric Capital Management LP-Sell$946.25K
Aug 08, 2025Freund John Gordon-Sell$400.64K
Jun 09, 2025Freund John Gordon-Sell$202.15K
Mar 20, 2025Tupper Colleen EVP & Chief Financial OfficerSell$36.18K

Insider Transactions Trends


DateBuySell
2025 Q3-3
2025 Q2-1
2025 Q1-18
2024 Q4--
2024 Q3-4

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 1.16%, followed by 1.44% insiders and 97.40% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.17%, which Collegium Pharmaceutical falls below.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.34M shares, 16.80%), Eventide asset management (2.64M shares, 8.31%), and Rubric capital management lp (2.35M shares, 7.28%). Together, they hold 32.39% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Tejara capital is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 1.47% of its assets in 107.34K Collegium Pharmaceutical shares, valued at 3.17M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.09% of its total shares outstanding invested in 1.92M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools